Nedocromil Sodium Suppliers & Bulk Manufacturers
Available Forms: Inhalation Form
Available Strengths: 2%
Reference Brands: Tilade® Inhaler(US & EU)
Category:
Allergy Medication
Nedocromil Sodium, once sold as Alocril® (eye drops) and Tilade® (inhaler), is a mast cell stabilizer used for allergic conjunctivitis and asthma. Though limited in the US and EU, it’s still available via GMP-certified manufacturers and can be sourced in bulk through Pharma B2B platforms like Pharmatradz.com.
Nedocromil Sodium is available in Inhalation Form
and strengths such as 2%.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Nedocromil Sodium is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Nedocromil Sodium can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Nedocromil Sodium is a mast cell stabilizer used to manage allergic conjunctivitis and mild asthma by preventing the release of histamine and other inflammatory mediators. Once marketed under brands like Alocril® (ophthalmic solution) and Tilade® (inhaler), it is now selectively available in global markets. Though discontinued in the US and limited in the EU, Nedocromil Sodium is still manufactured under GMP-compliant conditions and can be sourced via Pharma B2B platforms like Pharmatradz.com. Ideal for niche demand, regulatory markets, and custom formulations, it remains relevant in specific therapeutic areas where preventive allergy control is essential.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing